Highlights Kadimastem Ltd

Equities

KDST

IL0011284614

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 13:49:49 12/05/2024 BST			5-day change	1st Jan Change
488.9 ^ILa	+2.07%		-3.85%	-17.55%

03-28	Kadimastem Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-28	IMC Announces Potential Reverse Merger With A Leading Clinical Cell Therapy Company	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kadimastem Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
IMC Announces Potential Reverse Merger With A Leading Clinical Cell Therapy Company	02-28	MT
Kadimastem Ltd entered into a non-binding term sheet to acquire IM Cannabis Corp. in reverse merger transaction.	02-27	CI
Kadimastem Plans Listing on Nasdaq Through Merger	02-18	CI
ITolerance, Inc. and Kadimastem Ltd. Submit Initial Targeted Engagement for Regulatory Advice on CBER Products	11-07	CI
Kadimastem Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23	CI
Kadimastem to Launch Clinical Trial in ALS Patients Upon Approval from the Hadassah Hospital IRB	22/06/17	CI
Kadimastem Receives Approval from the IRB (Helsinki Committee) of the Hadassah Ein Kerem Hospital for the Phase 1/2A Clinical Trial in Als Patients	21/06/17	CI
Kadimastem Announces Granting a Patent in the US for Treatment of Neurodegenerative Diseases	16/03/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer